AbbVie reconsidering deal with Shire

SHARE AbbVie reconsidering deal with Shire

The North Chicago-based drugmaker is having second thoughts about its $55 billion deal to combine with British counterpart Shire. AbbVie said late Tuesday its board needs to weigh whether it is still a good idea in light of new U.S. tax regulations aimed at cracking down on corporate inversions. Shire called on AbbVie to stick to the deal, reminding its partner about the hefty $1.64 billion breakup fee.

Continue reading at Newsfeed

The Latest
The man was found in the lake about 12:20 a.m. and transported to Weiss Hospital, where he died.
Prosecutors say they will call multiple women who claim they had sex with R&B star as minors during the trial.
Grandma doesn’t enjoy interacting with the disrespectful 16-year-old.
Aykroyd and Jim Belushi will team up to perform at the fest, which also features local blues music and a re-creation of Chicago’s Maxwell Street Market.
The state committed itself to change by entering into a consent decree in the Lippert vs. Jeffreys class action lawsuit on prison medical care in 2018, but an acceptable plan to provide care has never been submitted to the court.